Narcolepsy is a sleep disorder in which patients are not able to maintain wakefulness or require treatment to maintain wakefulness during the daytime. Narcolepsy is a lifelong neurologic disease for which no cure has been clinically available. JZP441 is currently being developed for the treatment of narcolepsy type 1 (NT1). This study will assess the safety of efficacy of JZP441 in adult patients with NTI.
Narcolepsy
Narcolepsy is a sleep disorder in which patients are not able to maintain wakefulness or require treatment to maintain wakefulness during the daytime. Narcolepsy is a lifelong neurologic disease for which no cure has been clinically available. JZP441 is currently being developed for the treatment of narcolepsy type 1 (NT1). This study will assess the safety of efficacy of JZP441 in adult patients with NTI.
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
-
Clinical Trial Site, Atlanta, Georgia, United States, 30328
Clinical Trial Site, Boston, Massachusetts, United States, 02114
Clinical Trial Site, Kenwood, Ohio, United States, 45245
Clinical Trial Site, Columbia, South Carolina, United States, 29201
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 64 Years
ALL
No
Jazz Pharmaceuticals,
Global Medical Lead, STUDY_DIRECTOR, Jazz Pharmaceuticals
2026-04-01